Articles

Summer’s over and the stock market’s most troublesome month is under way. But looking beyond September — and October, for that matter — the historical data are more encouraging.

Starliner is slated to return to Earth empty, while its crew will stay on the International Space Station for a few more months.

Construction spending fell 0.3% in July, the Commerce Department reported Tuesday.

Shares are among leading S&P 500 gainers early in Tuesday action as Super Micro looks to reassure customers

A key barometer of U.S. factories was negative for the fifth straight month, signaling the manufacturing side of the economy is still in a deep slump that might not end until after the presidential election.

The Phase 2 trial was evaluating the vaccine called VLA15 following a second booster dose given one year after the first one.

Vaxcyte Inc.’s stock soared 42% Tuesday, after the vaccine maker reported positive results from an early-stage trial of its 31-valent pneumococcal conjugate vaccine candidate in adults aged 50 and older.

Transocean’s stock headed lower in early Tuesday trading, after the oil services company said it expects to book impairment charges of more than $600 million for the sale of assets.

Tighter Bank of Japan policy and falling optimism over U.S. tech earnings may spark more turmoil.

Nvidia’s gross margins could fall due to a rapid product cadence, but demand remains robust.

Deutsche Bank analyst Matt O’Connor sees little upside for JPM after stock’s 32% YTD rise.

While Intel shares look inexpensive based on their multiple of book value, one analyst says he sees “easier ways to generate returns elsewhere.”